Inhibitors of farnesyl-protein transferase

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

544331, 544242, 544322, A61K 31506, C07D23902

Patent

active

060515740

ABSTRACT:
The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.

REFERENCES:
patent: 4713387 (1987-12-01), Watanabe et al.
patent: 5428164 (1995-06-01), Thurkauf et al.
patent: 5573313 (1996-11-01), Fisher et al.
patent: 5587390 (1996-12-01), Salimbeni et al.
patent: 5593991 (1997-01-01), Adams et al.
patent: 5633376 (1997-05-01), Thurkauf et al.
patent: 5883105 (1999-03-01), Anthony
Chem. Abs: Lee et al., 122: 314-567 1995.
Exp. Opin. Ther. Patents (1996) 6(12):1295-1304 Graham et al "Oncologic, Endocrine & Metabolic / Inhibitors of Protein Farnesylation".
J. of Bio. Chem., vol. 268, No. 11, 7617-7620 (1993) Gibbs et al "Selective Inhibition o Farnesyl-Protein Transferase Blocks Ras Processing in Vivo".
J. of Bio. Chem., vol. 269, No. 44, 27706-27714 (1994) James et al "Benzodiazepine Peptidomimetic BZA-5B Interrupts the MAP Kinase Activition Pathway in H-Ras-transformed Rat-1 Cells, but not in Untransformed Cells".
J. of Bio. Chem., vol. 270, No. 11, 6221-6226 (1995) James et al "Polylysine and CVIM Sequences of K-RasB Dictate Specificity of Prenylation and Confer Resistance to Benzodiazepine Peptidomimetic in Vitro".
Science, vol. 260, 1934-1937 (1993) Kohl et al "Selective Inhibition of ras-Dependent Transformation by a Farnesyltransferase Inhibitor".
Proc. Natl. Acad. Sci. US, vol. 91, 9141-9145 (1994) Kohl et al "Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice".
Nature Medicine, vol. 1, No. 8, 792-797 (1995) Kohl et al "Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice".
Cancer Research vol. 55, 5302-5309 (1995) Sepp-Lorenzino et al "A Peptidomimetic Inhibitor of Farnesyl:Protein Transferase Blocks the Anchorage-dependent and -independent Growth of Human Tumor Cell Lines".
Chemical Abstracts 8207h, vol. 110 (1989) Takasugi et al "Preparation and testing of pyridlimidazoles as cardiotonics, inflammation inhibitors, and blood platelet aggregation inhibitors".

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Inhibitors of farnesyl-protein transferase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of farnesyl-protein transferase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of farnesyl-protein transferase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2336557

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.